Posts Tagged ‘reverse cholesterol transport’

RSS

November 18th, 2014

Don’t Count the Numbers. HDL Function Looks Like the Key

A new study offers important evidence explaining the protective role of HDL cholesterol against cardiovascular disease. Previous studies with drugs that increase HDL levels, including niacin and CETP inhibitors, have not been found beneficial. The new study suggests that simply increasing HDL levels isn’t useful. Instead, cholesterol efflux, the ability of HDL to remove cholesterol from […]


June 28th, 2013

More Bad News for HDL Therapies: ASSURE Trial Misses Primary Endpoint

The string of bad news for HDL-related therapies continues. Resverlogix yesterday announced that the ASSURE clinical trial had failed to meet its primary endpoint. RVX-208, the drug being studied in the trial, is a novel small molecule that increases production of Apolipoprotein A-I (ApoA-1), which raises HDL levels and is thought to enhance reverse cholesterol transport. ASSURE was a […]